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Abstract: Chronic obstructive pulmonary disease (COPD) patients are characterised for presenting
dyspnea, which reduces their physical capacity and tolerance to physical exercise. The aim of
this study was to analyse the effects of adding a Feel-Breathe (FB) device for inspiratory muscle
training (IMT) to an 8-week pulmonary rehabilitation programme. Twenty patients were randomised
into three groups: breathing with FB (FBG), oronasal breathing without FB (ONBG) and control
group (CG). FBG and ONBG carried out the same training programme with resistance, strength and
respiratory exercises for 8 weeks. CG did not perform any pulmonary rehabilitation programme.
Regarding intra group differences in the value obtained in the post-training test at the time when
the maximum value in the pre-training test was obtained (PostPRE), FBG obtained lower values in
oxygen consumption (VO2, mean = −435.6 mL/min, Bayes Factor (BF10) > 100), minute ventilation
(VE, −8.5 L/min, BF10 = 25), respiratory rate (RR, −3.3 breaths/min, BF10 = 2), heart rate (HR,
−13.7 beats/min, BF10 > 100) and carbon dioxide production (VCO2, −183.0 L/min, BF10 = 50), and
a greater value in expiratory time (Tex, 0.22 s, BF10 = 12.5). At the maximum value recorded in the
post-training test (PostFINAL), FBG showed higher values in the total time of the test (Tt, 4.3 min,
BF10 = 50) and respiratory exchange rate (RER, 0.05, BF10 = 1.3). Regarding inter group differences
at PrePOST, FBG obtained a greater negative increment than ONBG in the ventilatory equivalent of
CO2 (EqCO2, −3.8 L/min, BF10 = 1.1) and compared to CG in VE (−8.3 L/min, BF10 = 3.6), VCO2
(−215.9 L/min, BF10 = 3.0), EqCO2 (−3.7 L/min, BF10 = 1.1) and HR (−12.9 beats/min, BF10 = 3.4).
FBG also showed a greater PrePOST positive increment in Tex (0.21 s, BF10 = 1.4) with respect to
CG. At PreFINAL, FBG presented a greater positive increment compared to CG in Tt (4.4 min, BF10
= 3.2) and negative in VE/VCO2 intercept (−4.7, BF10 = 1.1). The use of FB added to a pulmonary
rehabilitation programme in COPD patients could improve tolerance in the incremental exercise
test and energy efficiency. However, there is only a statically significant difference between FBG
and ONBG in EqCO2. Therefore, more studies are necessary to reach a definitive conclusion about
including FB in a pulmonary rehabilitation programme.
Keywords: chronic pulmonary obstructive pulmonary disease; inspiratory muscle training; physical
exercise; cardiopulmonary exercise test
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1. Introduction
Chronic obstructive pulmonary disease (COPD) is considered as one of the main
causes of morbidity and mortality worldwide [1]. This disease is characterised for causing
a chronic limitation of the air flow, which leads to dyspnea, mainly when making an effort,
thus reducing physical capacity and worsening the quality of life [2]. Training with physical
exercise is considered one of the pillars within pulmonary rehabilitation programmes in
the treatment of COPD, since it is an effective way of delaying physical deterioration and
the consequent functional limitation in COPD patients [1,3].
The standard prescription of physical exercise includes cardiorespiratory capacity
training, through either walking or cycling, and muscle strength training, for both the
upper and lower limbs [4]. Additionally, inspiratory muscle training (IMT) has proved
to be an effective method to reduce dyspnea, increase physical capacity and improve
the quality of life [5,6]. However, IMT is rarely included in pulmonary rehabilitation
programmes, since it does not seem to provide an additive effect when used with other
forms of training [6–9]. This result can be partly due to the fact that IMT is carried out
separately and not concurrently with exercise, which has been shown to have an ergogenic
effect on healthy people [10]. In fact, there are different devices for IMT in COPD patients,
although the training is performed in a static position, usually with the individual sitting,
thus without simultaneously activating the skeletal muscles involved in the exercise for
both cardiorespiratory capacity and muscle strength training.
In a recent study, a ventilatory flow filtering and restricting device called FeelBreathe®
(FB) (University of Cádiz, Cádiz, Spain), which is placed under the nostrils, was designed
to increase the resistance to the nasal air flow [11]. This device is made of hypoallergenic
material and designed in different sizes and porosity. The larger one makes inspiration
more difficult. Previous studies in COPD patients using FB have reported improvements
in ventilatory efficiency and pattern, as well as increased inspiratory and expiratory time
during exercise [12]. FB has also been reported to provide improvements in dyspnea,
quality of life, exercise tolerance and inspiratory muscle strength after using it in an 8-week
pulmonary rehabilitation programme [13].
Cardiopulmonary exercise testing has become a key tool to analyse the efficacy of
pulmonary rehabilitation programmes in COPD patients, since it allows monitoring the
metabolic and cardiorespiratory response with the aim of identifying patterns of functional
deterioration and measuring exercise tolerance [14,15]. In fact, there are specific guidelines
to obtain and interpret results in this test with COPD patients [16,17]. The limitation in this
type of exercise in a COPD patient is related to an inefficient exchange of gases in the lungs,
muscle deconditioning and dynamic pulmonary hyperinflation [15]. An effective training
programme will produce adaptations related to these physiopathologies with the aim of
improving the general physical performance.
Therefore, the aim of this study was to analyse the effects of using a FB device, in
an 8-week pulmonary rehabilitation programme, on the exercise performance of COPD
patients to tolerate exercise, measured through cardiopulmonary exercise testing. Our
hypothesis is that the use of FB during training will have an additive effect, producing
greater adaptations in the respiratory muscles and, thus, an even greater increase of the
physical capacity compared to the training without FB.
2. Materials and Methods
2.1. Sample Size Calculation
Sample size calculations were performed for intra-group and inter-group differences
using G*Power software version 3.1 (University of Düsseldorf, Düsseldorf, Germany).
According to the results of the F test, a sample of 30 participants is needed to obtain a
significance difference between measures obtained intra-group (statistical test: analysis of
variance (ANOVA), repeated measures, within factors. Required input parameters: effect
size = 0.25, level of significance α = 0.05, power β = 0.80, number of measurements = 3,
correlation among repeated measures = 0.5). Regarding inter-group differences, a sample
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of 108 participants is needed to obtain a significance result (statistical test: ANOVA,
repeated measures, between factors. Required input parameters: effect size = 0.25, level
of significance α = 0.05, power β = 0.80, number of groups, number of measurements = 3,
correlation among repeated measures = 0.5).
2.2. Design
This study was designed as a clinical trial (NCT 01695265) in which the participants
were assigned to the following three groups by stratified randomisation: physical training
and IMT with FB (FBG); physical training without IMT (ONBG); and control group, i.e.,
no training (CG). FB has been authorized for use in the present study by the Spanish
Agency for Medicine and Health Products (File 521/15/EC, AEMPS, Madrid, Spain). The
randomisation process was performed using the randomizeR package for programming
language R [18]. All patients, before initiating the rehabilitation programme, received a
document with information about the study, and, after agreeing to participate in it, they
signed the informed consent form. This clinical trial was approved by the Ethics and
Research Committee of the University Hospital Puerta del Mar (Cádiz, Spain), and met the
requirements of the declaration of Helsinki and the data protection law.
2.3. Participants
The inclusion criteria to participate in this study were as follows: patients diagnosed
with COPD according to the GOLD (Global Initiative for Obstructive Lung Disease) cri-
teria [2], between 35 and 70 years old, degree of dyspnea ≥2 in the modified dyspnea
scale [19] and stable clinical condition for at least 2 months. On the other hand, the study
excluded the patients with the following characteristics: any possibility of heart disease,
neuromuscular or skeletal diseases that limited the patient’s physical performance, dysp-
nea at rest, the need for supplementary oxygen, CO2 retention or the use of any mechanical
ventilation support.
Thus, 36 patients were eligible for the study at the University Hospital Puerta del
Mar (Cádiz, Spain), of whom 6 refused to participate and 10 did not meet one or more
inclusion criteria. Two patients assigned to ONBG left the study during the final tests and
two participants from CG were discarded for not attending the final tests and presenting
exacerbated COPD. Finally, 16 individuals completed the study (Figure 1).
2.4. Training Programme
The participants of FBG and ONBG carried out a weekly 3-day training plan for
8 weeks following the exercise recommendations for COPD patients [20]. Each training
session, with a total duration of 60 min, consisted in 15 min of general warm-up, followed
by cardiorespiratory capacity improvement exercises, muscle-strengthening exercises and,
lastly, respiratory exercises (see Supplementary Materials for a detailed description). Addi-
tionally, joint mobility and flexibility exercises were included.
The training session was divided into a warm-up phase, main phase and return to
calmness, with the first two sessions being dedicated to the introduction to and familiarisa-
tion with the facilities, the trainer and the exercises. The participants were not asked to
go for the next phase or exercise if they found it difficult to tolerate the previous phase or
exercise. After each training session, the participants were subjected to a 1–10 perceived
exertion scale, ensuring that scores of 8–9 were never reached.
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Figure 1. Flowchart of the study.
CG did not carry out any programmed physical activity, i.e., the participants of
the control group only performed the physical activity that is usually recommended by
their pulmonologist.
The exercises for the improvement of the cardiorespiratory capacity were conducted
at an intensity of 60–70% of the participant’s heart rate reserve, which was individually
controlled using pulsometers (Polar Electro, Kempele, Finland) and measured through the
perceived exertion scale [21]. Depending on the session, the exercise was performed on a
running track, a treadmill or a stationary bicycle. The volume varied from 10 min in the
first three sessions to 25 min in the last sessions.
For the strength exercises, we individually determined the intensity that allowed
performing 3 sets of 8–12 repetitions in each of the exercises until reaching muscle fatigue.
Once the participant was able to perform more than 12 repetitions for two consecutive
training sessions, the intensity was increased by 2–5 kg, depending on the exercise, while
maintaining the same volume. The exercises were performed with fitness machines for
both upper and lower limbs.
The respiratory exercises, conducted at the end of each session, consisted in exercises
with pursed lips, diaphragmatic, abdominal and thoracic breathing, and techniques of
pulmonary expansion and rib cage mobilisation. The patients stretched the muscle groups
that were worked out in each session.
During the first training week, the FBG participants used the 4 mm FB device, which
was replaced with a larger FB (5–6 mm) depending on the adaptation and improvement
of the individual. The FB was placed under the nostrils using sterile gloves and ensuring
that the participant did not have mucus or injuries (Figure 2). All participants, during the
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execution of the exercises, were asked to breathe correctly through nasal inspirations and
mouth expirations.
Figure 2. Types (left) and positioning (right) of the FeelBreathe device.
All training sessions were directed by Graduates in Physical Activity and Sports
Science and supervised by each participant’s specialist pulmonologist.
2.5. Cardiopulmonary Exercise Test
An incremental cardiopulmonary exercise test on a treadmill (Technogym Run Race
1400HC, Gambettola, Italy) was carried out by all participants before initiating the training
programme and 2 days after its termination. The protocol for the realisation of the incre-
mental test on a treadmill for COPD patients has been previously described [22,23]. The
ventilatory variables and those of gas exchange were measured throughout the entire test
using a gas analyser (Jaeger-CareFusion, MasterScreen CPX model, Hoechberg, Germany).
The oxygen consumption (VO2), carbon dioxide production (VCO2), minute ventilation
(VE), breathing frequency (BF), heart rate (HR), inspiratory tidal volume (VTin), expiratory
tidal volume (VTex), inspiratory time (Tin), expiratory time (Tex), breathing cycle (TiTot),
ventilatory equivalent of O2 (EqO2) and CO2 (EqCO2), end-tidal O2 and CO2 (PETO2 and
PETCO2, respectively) and respiratory exchange rate (RER) were recorded respiration by
respiration. Additionally, the total time of the test (Tt) was recorded, and we calculated the
lowest point in the curve that describes the relationship between VE and VCO2 (VE/VCO2
nadir) and the intercept and slope of the regression line that corresponded to the relation-
ship between VE and VCO2 (VE/VCO2 intercept and VE/VCO2 slope, respectively). These
variables represent the ventilatory efficiency of the patient during the cardiopulmonary
exercise test and are related to the risk of mortality of the COPD patient [24–26].
VE/VCO2 intercept, intercept of the regression line VE/VCO2; VE/VCO2 nadir,
lowest point in the curve that describes the relationship between VE/VCO2; VE/VCO2
slope, slope of the regression line VE/VCO2.
2.6. Statistical Analysis
The results of this study are presented as mean ± standard deviation. For the analysis
of the cardiorespiratory variables, we obtained the values of 3 different time points during
the cardiopulmonary exercise test: the maximum value obtained during the pre-training
test (Pre), the value obtained in the post-training test at the time when the maximum value
in the pre-training test was obtained (PostPRE) and the maximum value recorded in the
post-training test (PostFINAL) (Figure 3 shows an example with VE). This analysis was
performed for each of training groups (i.e., FBG, ONBG and CG).
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Figure 3. Graphical representation of temporal points selected for statistical analyses.
Intra- and inter-group differences were analysed using a Bayesian hierarchical regres-
sion model. For their estimation, all the hyper-parameters of the model had an a priori
probability distribution with little information (i.e., a probability distribution that has
enough information to restrict the range of values while leaving a wide range of uncovered
values) [27]. The brms package for R programming language and data analysis was used
to estimate the parameters of the model [28]. The Bayes factors were used to quantify
the level of evidence of the results [29]. Additionally, the percentage of change between
Pre and PostPRE and between Pre and PostFINAL was calculated using the formula: (Post
value − Pre value)/Pre value * 100. Increments (∆) from Pre to PostPRE and PostFINAL were
calculated as mean and 95% highest density interval (HDI). HDI is a special case of credible
interval which summarizes the uncertainty of the parameter estimated in such a way that
any parameter value inside a 95%HDI are the 95% most credible values. All the results can
be found in the supplementary materials (table format) while the significant results are
displayed graphically in the results section.
3. Results
3.1. Descriptive Characteristics
The descriptive characteristics of the participants at the beginning of the study are
shown in Table 1. ONBG obtained a lower FVC than CG (−665 mL (1317, 23), BF10 > 100).
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Table 1. Descriptive characteristics of the sample.
Variables FBG (n = 7) ONBG (n = 5) CG (n = 4) FBG vs. ONBG BF10 FBG vs. CG BF10 ONBG vs. CG BF10
Age (years) 65.0 ± 8.0 72.0 ± 7.4 70.2 ± 5.9 −4.8 (−14.8, 6.2) 0.1 −6.6 (−15.5, 3.6) 0.3 1.7 (−10.0, 12.9) 0.1
BMI (m/kg2) 28.4 ± 4.2 26.8 ± 2.5 25.9 ± 2.1 1.5 (−2.4, 5.4) 0.3 2.3 (−2.0, 6.3) 0.2 0.8 (−3.6, 5.5) 0.2
FEV1 (mL) 1571 ± 334 1608 ± 344 1812 ± 706 −23.5 (−557, 469) 0.1 −218 (−760, 349) 0.1 194 (−441, 773) 0.1
FEV1 (% predicted) 46.9 ± 10.6 51.2 ± 9.8 52.6 ± 19.9 −3.7 (−18.4, 11.1) 0.1 −5.4 (−21.6, 10.8) 0.1 −1.8 (−19.8, 16.1) 0.1
FVC (mL) 2869 ± 298 2580 ± 577 3270 ± 474 283 (−260, 801) 0.3 −382 (−929, 207) 0.1 −665 (−1317, −22.9) >100
FVC (% predicted) 63.9 ± 8.3 59.2 ± 10.0 67.1 ± 13.8 4.5 (−7.4, 17.1) 0.3 −3.1 (−15.9, 10.1) 0.1 −7.6 (−21.5, 7.7) 0.3
FEV/FVC (%) 54.1 ± 6.9 62.6 ± 5.6 54.2 ± 14.7 −8.1 (−18.7, 2.8) 0.2 0.0 (−11.4, 11.4) 0.1 8.1 (−4.2, 20.8) 0.3
PImax (mmHg) 93.3 ± 19.1 85.6 ± 23.9 102.0 ± 14.9 7.9 (−15.6, 31.1) 0.1 −7.6 (−34.3, 17.3) 0.2 −15.5 (−42.8, 12.5) 0.2
CAT (score) 9.7 ± 6.5 10.0 ± 4.5 6.8 ± 4.4 −0.3 (−6.8, 6.4) 0.1 2.7 (−3.8, 9.7) 0.2 3.0 (−4.5, 10) 0.1
mMRC (score|%) P(Y|FB) P(Y|ONB) P(Y|CG)
0 0 (0%) 0 (0%) 0 (0%) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0) 0.0 (0.0, 0.0)
1 0 (0%) 0 (0%) 0 (0%) 0.0 (0.0, 0.1) 0.0 (0.0, 0.2) 0.0 (0.0, 0.2)
2 6 (85%) 5 (100%) 4 (100%) 0.9 (0.6, 0.1) 0.9 (0.7, 1.0) 0.9 (0.7, 1.0)
3 1 (15%) 0 (0%) 0 (0%) 0.1 (0.0, 0.4) 0.0 (0.0, 0.2) 0.0 (0.0, 0.3)
FBG, training + breathing with FeelBreathe group; ONBG, training + breathing without FeelBreathe group; CG, control group; BMI, body mass index; FEV1, forced expiratory volume in 1 s; FVC, forced vital
capacity; HDI, highest density interval; PImax, maximal inspiratory pressure; CAT, COPD Assessment Test; mMRC, modified Medical Research Council dyspnea scale; P(Y|FB), P(Y|ONB) and P(Y|GC),
probability of answer the score Y (i.e., 0, 1, 2, 3), given the participant was assigned to a group at baseline. 95% highest density intervals that does not include 0 for continuous variables or 0.5 for categorical
variables are highlighted in bold.
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3.2. Intra-Group Differences
FBG (Figure 4) obtained lower PostPRE values in VO2 (−435.6 mL/min (−626.0,
−248.4), BF10 > 100), VE (−8.5 L/min (−12.8,−3.9), BF10 = 25), RR (−3.3 breaths/min (−5.9,
−0.8), BF10 = 2), HR (−13.7 beats/min (−20.3, −7.1), BF10 > 100) and VCO2 (−183.0 L/min
(−313.0, −57.6), BF10 = 50), and a greater value in Tex (0.22 s (0.10, 0.33), BF10 = 12.5).
At PostFINAL, FBG obtained a greater value in Tt (4.3 min (1.8, 6.4), BF10 = 50) and RER
(0.05 (0.01, 0.10), BF10 = 1.3). ONBG (Figure 5) showed a lower PostPRE value in HR
(−9.0 beats/min (−16.6, −1.5), BF10 = 1.5). Lastly, CG (Figure 6) obtained a greater value
in the ordinate axis of VE/VCO2 (4.9 (0.7, 8.9), BF10 = 2.2).




Figure 4. Significant intra-group differences for FBG in VO2 (A), VE (B), BF (C), VCO2 (D), HR (E), Tex (F), RER (G) and Tt 
(H). %Change indicates percentage of change; Δ, increment; BF10, Bayes Factor; HDI, highest density interval. Significant 
differences are highlighted in bold. 
Commented [GT1]: The two top figures are both 
labelled as B, please add in A.  
Commented [MOU2R1]: Done 
Figure 4. Significant intra-group differences for FBG in VO2 (A), VE (B), BF (C), VCO2 (D), HR (E), Tex (F), RER (G) and Tt
(H). %Change indicates percentage of change; ∆, increment 10, Bayes Factor; HDI, highest density nterval. Significant
differences are highlighted in bold.
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Figure 5. Significant intra-group difference for ONBG in HR. %Change indicates percentage of change;
∆, increment; BF10, Bayes Factor; HDI, highest density interval. Significant differences are highlighted
in bold.
Figure 6. Significant intra-group difference for CG in VE/VCO2 intercept. %Change indicates percent-
age of change; ∆, increment; BF10, Bayes Factor; HDI, highest density interval. Significant differences
are highlighted in bold.
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3.3. Inter-Group Differences
The inter-group differences in the reached increments are shown in Figure 7. At
PrePOST, FBG obtained a greater negative increment than ONBG in EqCO2 (−3.8 L/min
(−7.3, −0.3), BF10 = 1.1) and compared to CG in VE (−8.3 L/min (−15.1, −1.4), BF10 = 3.6),
VCO2 (−215.9 L/min (−404.0, −32.7), BF10 = 3.0), EqCO2 (−3.7 L/min (−7.3, −0.0),
BF10 = 1.1) and HR (−12.9 beats/min (−23.2, −2.6), BF10 = 3.4). FBG also showed a greater
PrePOST positive increment in Tex (0.21 s (0.02, 0.39), BF10 = 1.4) with respect to CG.
Figure 7. Significant inter-group differences between FBG and ONBG in EqCO2 at PostPRE (A); between FBG and CG in
VE (B), VCO2 (C), EqCO2 (D), HR (E) and Tex (F) at PostPRE; and between FBG and CG in Tt (G) and VE/VCO2 intercept
(H). %Change indicates percentage of change; ∆, increment; BF10, Bayes Factor; HDI, highest density interval. Significant
differences are highlighted in bold.
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At PostFINAL, FBG presented a greater positive increment compared to CG in Tt
(4.4 min (0.9, 7.9), BF10 = 3.2) and negative in the VE/VCO2 intercept (−4.7 (−8.8, −0.5),
BF10 = 1.1).
4. Discussion
To the best of the authors’ knowledge, this is the first study to consider IMT con-
currently with exercise training in COPD patients. The main finding of this work is that,
after 8 weeks of concurrent training of the cardiorespiratory capacity, muscle strength and
IMT with FB, the COPD patients showed improvements in muscle dysfunction, exercise
tolerance, physical performance and ventilatory efficiency. On the other hand, those partic-
ipants who only performed the cardiorespiratory capacity and muscle strength training
without IMT did not experience any relevant changes.
In general, the improvement in physical performance after the training in FBG is
shown by the fact that they obtained a greater total time in the test (62.5% ↑), caused by an
improvement in cardiopulmonary efficiency (i.e., lower VO2 for the same load). Lower VO2
(27.9% ↓) and HR (12.3% ↓) at PrePOST could be due to a more efficient use of oxygen, after
a decrease of the mitochondrial oxidative stress in the skeletal muscle [30,31]. Moreover,
lower VE (24.8% ↓), RR (13.3% ↓) and VCO2 (23.9% ↓) and greater Tex (14.7% ↑) at PrePOST
indicate an improvement in ventilatory efficiency.
These changes were similar to, although slightly lower than, those reported by
Casaburi et al. [32], who found a decrease in VO2 (6% ↓), HR (8% ↓), VE (15% ↓) and
VCO2 (11% ↓) for the same exercise intensity after a 6-week pulmonary rehabilitation pro-
gramme based on interval training with cycle ergometer. The difference in the magnitude
of the changes can be due to the fact that the participants only trained the cardiorespiratory
capacity (although at high intensity), they did not perform concurrent IMT training and
the duration of the mentioned study was shorter.
In this study there was an improvement in many of the analyzed parameters in the
FBG compare with the ONBG at PostFINAL but they did not reach statistical significance,
probably due to sample size, however, the FBG reached 2.1 min more that the ONBG at
the end of the cardiopulmonary exercise test what is more than 100 s that is considered
as the minimal clinical important difference [33]. VO2, VE and EqCO2 were reduced
in the PostPRE, being the EqCO2 statistically significant. These findings indicate that
patients in the FBG only showed one statically significant difference in the respiratory
response compared to the ONBG. Therefore, more studies are necessary to reach a definitive
conclusion about including FB in a pulmonary rehabilitation programme.
Recent studies have not found an additive effect of IMT in a pulmonary rehabilitation
programme on the capacity to perform physical exercise [7–9]. Wang et al. [9] reported that
there were no statistically significant differences between those participants who carried
out 8-week aerobic training on a cycle ergometer added to an IMT and those who only
conducted the aerobic training, although both groups obtained a significant improvement
in the capacity to perform exercise. Similarly, Beaumont et al. [7] did not find differences at
the end of a 4-week training between groups in the 6 min walk test (6MWT). Lastly, Schultz
et al. [8], despite analysing a large sample of COPD patients (n = 561), only conducted the
experiment for 3 weeks, concluding that IMT did not provide an additional gain in the
physical capacity measured through the 6MWT. These results could be partly because the
IMT was carried out in addition to the training sessions, using a threshold device, which
cannot be used concurrently with exercise. Therefore, the use of devices such as FB for IMT
during physical exercise may be a burden that could adequately induce respiratory muscle
fatigue and cause adaptations for the improvement of physical performance [34–36].
Regarding the execution of strength exercises, it was observed that both FBG and
ONBG ostensibly improved their capacity to mobilise loads, although the real improvement
of this capacity is unknown, since initial and final tests about the maximum mobilised
load were not conducted. Similar programmes with strength exercises have been applied
in COPD patients, thus it is recommended to include it in respiratory rehabilitation pro-
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grammes. The effect of FB during the execution of these exercises, which involve maximum
inspirations and expirations, could have influenced the fact that FBG obtained better results
than ONBG.
This study has several limitations, with the main one being the small sample size and
the final sample imbalance of the groups. To solve this problem, we applied a Bayesian
inference process (i.e., quantifying the uncertainty about a given amount based on the
available data and previous information), incorporating information about the parameters
of interest to the a priori distributions to obtain a reliable estimation of such values. Another
limitation was that, due to the characteristics of the FB device, it was not possible to perform
a double-blind design for the intervention. Lastly, the sample was only constituted by men,
thus the results obtained cannot be extrapolated to the women.
5. Conclusions
The use of the FB device during a pulmonary rehabilitation programme improves
exercise tolerance and ventilatory efficiency and induces changes in the ventilatory pattern
that could lead to a reduction of the dynamic hyperinflation. This simple device, known as
FB, could be a useful tool for the IMT of COPD patients outside of the hospital or health
centre, since it can be worn while performing activities of daily living.
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test (PostFINAL – Value). Table S3: Mean of the maximum value obtained by the control group (CG)
in each variable in the pre-training test (Pre-Value) and maximum value obtained in the post-training
test (PostFINAL – Value).
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Abbreviations
BF10:Bayes factor; BF, breathing frequency; CAT, COPD Assessment Test; EqO2, ventilatory equiv-
alent of O2; EqCO2, ventilatory equivalent of CO2; FEV1, forced expiratory volume in 1 s; FVC,
forced vital capacity; HDI, highest density interval; mMRC, modified Medical Research Council
dyspnea scale; PETCO2, end-tidal CO2; PETO2, end-tidal O2; PImax, maximal inspiratory pressure;
Pre, pre-training test; PostPRE, value obtained in the post-training test at the time when the maximum
value in the pre-training test was obtained; PostFINAL, maximum value obtained in the post-training
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test; RER, respiratory exchange rate; Tex, expiratory time; Tin, inspiratory time; TiTot, breathing cycle;
Tt, total test time; VCO2, carbon dioxide production; VE, minute ventilation; VE/VCO2 intercept,
intercept of the regression line VE/VCO2; VE/VCO2 nadir, lowest point in the curve that describes
the relationship VE/VCO2; VE/VCO2 slope, slope of the regression line VE/VCO2; Vtex, expiratory
tidal volume; VO2, oxygen consumption; Vtin, inspiratory tidal volume.
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